The Editor’s Roundtable: Chronic Stable Angina Pectoris

Published:October 29, 2007DOI:https://doi.org/10.1016/j.amjcard.2007.09.001
      This CME activity is sponsored by an educational grant from CV Therapeutics, Palo Alto, California.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosamund W.
        • Flegal K.
        • Friday G.
        • Furie K.
        • Go A.
        • Greenland K.
        • Haase N.
        • Ho M.
        • Howard V.
        • Kissela B.
        • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
        Heart disease and stroke statistics—2007 update: a report from the American Heart Associations Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2007; 115: e69-e171
        • Prinzmetal M.
        • Kennamer R.
        • Merliss R.
        A variant form of angina pectoris.
        Am J Med. 1959; 27: 375-388
        • Boden W.E.
        • O’Rourke R.A.
        • Teo K.K.
        • Hartigan P.M.
        • Maron D.J.
        • Kostuk W.J.
        • Knudtson M.
        • Dada M.
        • Casperson P.
        • Harris C.L.
        • Chaitman B.R.
        • Shaw L.
        • Gosselin G.
        • Nawaz S.
        • Title L.S.
        • Gau G.
        • Blaustein A.S.
        • Booth D.C.
        • Bates E.R.
        • Spertus J.A.
        • Berman D.S.
        • Mancini J.
        • Weintraub W.S.
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Pepine C.J.
        Does the brain know when the heart is ischemic?.
        Ann Intern Med. 1996; 124: 1006-1008
        • Chan A.T.
        • Manson J.E.
        • Feskanich D.
        • Stampfer M.J.
        • Colditz G.A.
        • Fuchs C.S.
        Long-term aspirin use and mortality in women.
        Arch Intern Med. 2007; 167: 562-572
        • Loscalzo J.
        Folate and nitrate-induced endothelial dysfunction.
        Circulation. 2001; 104: 1086-1088
        • Poole-Wilson P.A.
        • Swedberg K.
        • Cleland J.G.
        • Di Lenarda A.
        • Hanrath P.M.D.
        • Komajda M.
        • Lubsen J.
        • Lutiger B.
        • Metra M.
        • Remme W.J.
        • Torp-Pedersen C.
        • Scherhag A.
        • Skene A.
        • COMET Investigators
        Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET).
        Lancet. 2003; 362: 7-13
        • Chaitman B.R.
        • Skettino S.L.
        • Parker J.O.
        • Hanley P.
        • Meluzin J.
        • Kuch J.
        • Pepine C.J.
        • Wang W.
        • Nelson J.J.
        • Hebert D.A.
        • Wolff A.A.
        • MARISA Investigators
        Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
        J Am Coll Cardiol. 2004; 43: 1375-1382
        • Chaitman B.R.
        • Pepine C.J.
        • Parker J.O.
        • Skopal J.
        • Chumakova G.
        • Kuch J.
        • Wang W.
        • Skettino S.L.
        • Wolff A.A.
        Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
        JAMA. 2004; 291: 309-316
        • Morrow D.A.
        • Scirica B.M.
        • Karwatowska-Prokopczuk E.
        • Murphy S.A.
        • Budaj A.
        • Varshavsky S.
        • Wolff A.A.
        • Skene A.
        • McCabe C.H.
        • Braunwald E.
        • MERLIN-TIMI 36 Trial Investigators
        Effects of ranolazine on recurrent cardiovascular events in patients with non–ST-elevation acute coronary syndromes.
        JAMA. 2007; 297: 1775-1783
        • Van den Brand M.J.B.M.
        • Rensing B.J.W.M.
        • Morel M.-aM.
        • Foley D.P.
        • de Valk V.
        • Breeman A.
        • Suryapranata H.
        • Haalebos M.M.P.
        • Wijns W.
        • Wellens F.
        • Balcon R.
        • Magee P.
        • Ribeiro E.
        • Buffolo E.
        • Unger F.
        • Serruys P.W.
        The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.
        J Am Coll Cardiol. 2002; 39: 559-564
        • Mann G.V.
        • Spoerry A.
        • Gary M.
        • Jarashow D.
        Atherosclerosis in the Masai.
        Am J Epidemiol. 1972; 95: 26-37